These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 31381072

  • 1. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
    Di Dalmazi G, Fanelli F, Zavatta G, Ricci Bitti S, Mezzullo M, Repaci A, Pelusi C, Gambineri A, Altieri P, Mosconi C, Balacchi C, Golfieri R, Cosentino ER, Borghi C, Vicennati V, Pasquali R, Pagotto U.
    J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5519-5528. PubMed ID: 31381072
    [Abstract] [Full Text] [Related]

  • 2. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
    Araujo-Castro M, Hanzu FA, Pascual-Corrales E, García Cano AM, Marchan M, Escobar-Morreale HF, Valderrabano P, Casals G.
    Endocrine; 2023 Oct 01; 82(1):161-170. PubMed ID: 37351760
    [Abstract] [Full Text] [Related]

  • 3. Steroid Profiling by LC-MS/MS in Nonsecreting and Subclinical Cortisol-Secreting Adrenocortical Adenomas.
    Di Dalmazi G, Fanelli F, Mezzullo M, Casadio E, Rinaldi E, Garelli S, Giampalma E, Mosconi C, Golfieri R, Vicennati V, Pagotto U, Pasquali R.
    J Clin Endocrinol Metab; 2015 Sep 01; 100(9):3529-38. PubMed ID: 26161451
    [Abstract] [Full Text] [Related]

  • 4. Steroidogenesis in patients with adrenal incidentalomas: Extended steroid profile measured by liquid chromatography-mass spectrometry after ACTH stimulation and dexamethasone suppression.
    Huayllas MKP, Smith LM, Gallagher JC, Netzel BC, Singh RJ, Kater CE.
    Clin Endocrinol (Oxf); 2021 Jul 01; 95(1):29-40. PubMed ID: 33598999
    [Abstract] [Full Text] [Related]

  • 5. Prevalence and Incidence of Atrial Fibrillation in a Large Cohort of Adrenal Incidentalomas: A Long-Term Study.
    Di Dalmazi G, Vicennati V, Pizzi C, Mosconi C, Tucci L, Balacchi C, Cosentino ER, Paolisso P, Fanelli F, Gambineri A, Pelusi C, Repaci A, Garelli S, Galiè N, Borghi C, Golfieri R, Pagotto U.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32413902
    [Abstract] [Full Text] [Related]

  • 6. Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism.
    Nakao H, Yokomoto-Umakoshi M, Nakatani K, Umakoshi H, Ogata M, Fukumoto T, Kaneko H, Iwahashi N, Fujita M, Ogasawara T, Matsuda Y, Sakamoto R, Izumi Y, Bamba T, Ogawa Y.
    EBioMedicine; 2023 Sep 01; 95():104733. PubMed ID: 37543511
    [Abstract] [Full Text] [Related]

  • 7. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
    Araujo-Castro M, Robles Lázaro C, Parra Ramírez P, Cuesta Hernández M, Sampedro Núñez MA, Marazuela M.
    Endocrine; 2019 Dec 01; 66(3):650-659. PubMed ID: 31473918
    [Abstract] [Full Text] [Related]

  • 8. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
    Araujo-Castro M, Parra Ramírez P, Martín Rojas-Marcos P, García Centeno R, Gracia Gimeno P, Tomé Fernández-Ladreda M, Sampedro Núñez MA, Higueruela C, Robles Lázaro C.
    Endocrine; 2023 Feb 01; 79(2):384-391. PubMed ID: 36261701
    [Abstract] [Full Text] [Related]

  • 9. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
    Remde H, Kranz S, Morell SM, Altieri B, Kroiss M, Detomas M, Fassnacht M, Deutschbein T.
    Front Endocrinol (Lausanne); 2023 Feb 01; 14():1123132. PubMed ID: 37223045
    [Abstract] [Full Text] [Related]

  • 10. Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study.
    Ceccato F, Tizianel I, Voltan G, Maggetto G, Merante Boschin I, Quaia E, Crimì F, Scaroni C.
    Front Endocrinol (Lausanne); 2021 Feb 01; 12():794197. PubMed ID: 34925247
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic accuracy of the different hormonal tests used for the diagnosis of autonomous cortisol secretion.
    Araujo-Castro M, García Cano A, Jiménez Mendiguchía L, Escobar-Morreale HF, Valderrábano P.
    Sci Rep; 2021 Oct 15; 11(1):20539. PubMed ID: 34654835
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas.
    Sbardella E, Minnetti M, D'Aluisio D, Rizza L, Di Giorgio MR, Vinci F, Pofi R, Giannetta E, Venneri MA, Vestri A, Morelli S, Lenzi A, Isidori AM.
    Eur J Endocrinol; 2018 May 15; 178(5):501-511. PubMed ID: 29510982
    [Abstract] [Full Text] [Related]

  • 13. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
    Araujo-Castro M, García Cano AM, Escobar-Morreale HF, Valderrabano P.
    Hormones (Athens); 2023 Mar 15; 22(1):51-59. PubMed ID: 36279032
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R.
    Lancet Diabetes Endocrinol; 2014 May 15; 2(5):396-405. PubMed ID: 24795253
    [Abstract] [Full Text] [Related]

  • 15. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F, Antonelli G, Frigo AC, Regazzo D, Plebani M, Boscaro M, Scaroni C.
    J Endocrinol Invest; 2017 Jul 15; 40(7):753-760. PubMed ID: 28247215
    [Abstract] [Full Text] [Related]

  • 16. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G, Vicennati V, Rinaldi E, Morselli-Labate AM, Giampalma E, Mosconi C, Pagotto U, Pasquali R.
    Eur J Endocrinol; 2012 Apr 15; 166(4):669-77. PubMed ID: 22267278
    [Abstract] [Full Text] [Related]

  • 17. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
    Levine AC, Mitty HA, Gabrilove JL.
    J Urol; 1988 Jul 15; 140(1):11-5. PubMed ID: 2967899
    [Abstract] [Full Text] [Related]

  • 18. Limited Role of Hair Cortisol and Cortisone Measurement for Detecting Cortisol Autonomy in Patients With Adrenal Incidentalomas.
    Puglisi S, Leporati M, Amante E, Parisi A, Pia AR, Berchialla P, Terzolo M, Vincenti M, Reimondo G.
    Front Endocrinol (Lausanne); 2022 Jul 15; 13():833514. PubMed ID: 35222288
    [Abstract] [Full Text] [Related]

  • 19. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 Aug 15; 49(2):165-71. PubMed ID: 9828902
    [Abstract] [Full Text] [Related]

  • 20. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M, Parra Ramírez P, Robles Lázaro C, García Centeno R, Gracia Gimeno P, Fernández-Ladreda MT, Sampedro Núñez MA, Marazuela M, Escobar-Morreale HF, Valderrabano P.
    Hormones (Athens); 2021 Dec 15; 20(4):735-744. PubMed ID: 34273083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.